{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:54:16Z","timestamp":1774421656423,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate changes in cystic-appearing macular lesions and visual acuity in patients with X-linked retinoschisis while being treated with a carbonic anhydrase inhibitor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective analysis of 68 eyes from 36 patients between the ages of 5 years and 61 years with X-linked retinoschisis were monitored while on a carbonic anhydrase inhibitor. Macular cystic-appearing lesions were monitored with optical coherence tomography. Snellen visual acuity measurements were converted to logarithm of the minimum angle of resolution equivalent Early Treatment Diabetic Retinopathy Study letters for analysis. Analyses for changes in both visual acuity and macular cysts included comparisons between treatment and pretreatment segments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-five eyes (66%) had a reduction of their cysts while on a carbonic anhydrase inhibitor. Twenty eyes (29%) showed no cystic change, whereas 3 eyes (4%) demonstrated worsening of their cysts with treatment when compared with pretreatment. There was a statistically significant improvement in logarithm of the minimum angle of resolution visual acuity while on treatment relative to pretreatment (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). The estimated average Early Treatment Diabetic Retinopathy Study equivalent improvement was 0.09 (slightly less than one line on the Early Treatment Diabetic Retinopathy Study chart) with a 95% confidence interval of 0.08 to 0.11.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Considering the entire 36 patients in this cohort, while statistically significant, the average improvement in visual acuity was modest. Nonetheless, in individual patients, the improvement was more substantial. Improvement in the extent of cystic macular lesions was observed in a high percentage of cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000001379","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T15:59:56Z","timestamp":1478707196000},"page":"1555-1561","source":"Crossref","is-referenced-by-count":24,"title":["USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS"],"prefix":"10.1097","volume":"37","author":[{"given":"Paola","family":"Andreuzzi","sequence":"first","affiliation":[{"name":"The Pangere Center for Hereditary Retinal Diseases, The Chicago Lighthouse, Chicago, Illinois;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald A.","family":"Fishman","sequence":"additional","affiliation":[{"name":"The Pangere Center for Hereditary Retinal Diseases, The Chicago Lighthouse, Chicago, Illinois;"},{"name":"Department of Ophthalmology, University of Illinois at Chicago, Chicago, Illinois; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230816","first-page":"343","article-title":"Ueber das zusammenvorkommen von veraenderungen der retina und choroidea","volume":"37","author":"Haas","year":"1898","journal-title":"Arch Augenheilkd"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2003.12.007","article-title":"X-linked retinoschisis: a clinical and molecular genetic review","volume":"49","author":"Tantri","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2011.12.002","article-title":"X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms","volume":"31","author":"Molday","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1167\/iovs.11-8600","article-title":"Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene","volume":"52","author":"Duncan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.iae.0000237081.80600.51","article-title":"Use of dorzolamide for patients with X-linked retinoschisis","volume":"26","author":"Apushkin","year":"2006","journal-title":"Retina"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2008.07.041","article-title":"Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin","volume":"147","author":"Walia","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archophthalmol.2009.398","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","article-title":"The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis","volume":"31","author":"Thobani","year":"2011","journal-title":"Retina"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10543409708835203","article-title":"An example of using mixed modes and PROC MIXED for longitudinal data","volume":"7","author":"Wolfinger","year":"1997","journal-title":"J Biopharm Stat"},{"key":"R13-20230816","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans Am Ophthalmol"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF00927256","article-title":"X-linked congenital retinoschisis","volume":"228","author":"Kellner","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201708000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T23:06:49Z","timestamp":1692227209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201708000-00016"}},"subtitle":["Effect on Cystic-Appearing Macular Lesions and Visual Acuity"],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001379","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}